Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Charles Weijer
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Concepts & Ideas
Procedures
Geographic Areas
Activities & Behaviors
Sign-in to see full Profile
Network (preview)
11
Miller, Paul
7
Fernandez, Conrad
6
Fuks, Abraham
6
Glass, Kathleen Cranley
5
Kodish, Eric
4
Shapiro, Stanley
4
Freedman, Benjamin
3
Lemmens, Trudo
3
Palmour, Roberta
2
Shurin, Susan
2
Anderson, James
1
Akabayashi, Akira
1
Kernerman, P
1
Kimmelman, Jonathan
1
Singer, Peter
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Charles Weijer (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Kimmelman Jonathan; Weijer Charles; Meslin Eric M
Helsinki discords: FDA, ethics, and international drug trials.
Lancet 2009;373(9657):13-4.
-
2007: Weijer Charles; Miller Paul B
Evaluating benefits and harms in intensive care research.
Intensive care medicine 2007;33(10):1819-22.
-
2007: Weijer C; Miller P B
Refuting the net risks test: a response to Wendler and Miller's "Assessing research risks systematically".
Journal of medical ethics 2007;33(8):487-90.
-
2007: Fernandez C V; Santor D; Weijer C; Strahlendorf C; Moghrabi A; Pentz R; Gao J; Kodish E
The return of research results to participants: pilot questionnaire of adolescents and parents of children with cancer.
Pediatric blood & cancer 2007;48(4):441-6.
-
2007: Miller Paul B; Weijer Charles
Equipoise and the duty of care in clinical research: a philosophical response to our critics.
The Journal of medicine and philosophy 2007;32(2):117-33.
-
2006: Fernandez Conrad V; Weijer Charles
Obligations in offering to disclose genetic research results.
The American journal of bioethics : AJOB 2006;6(6):44-6; author reply W10-2.
-
2006: Miller P B; Weijer C
Trust based obligations of the state and physician-researchers to patient-subjects.
Journal of medical ethics 2006;32(9):542-7.
-
2006: Weijer Charles; Leblanc Guy J
The balm of Gilead: is the provision of treatment to those who seroconvert in HIV prevention trials a matter of moral obligation or moral negotiation?
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2006;34(4):793-808.
-
2006: Miller Paul B; Weijer Charles
Fiduciary obligation in clinical research.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2006;34(2):424-40.
-
2005: Weijer Charles
Meaningful work as due inducement.
Theoretical medicine and bioethics 2005;26(5):431-5.
-
2004: Weijer Charles
The quest for legitimacy: comment on Cox Macpherson's 'To strengthen consensus, consult the stakeholders'.
Bioethics 2004;18(3):293-300.
-
2004: Weijer Charles; Miller Paul B
When are research risks reasonable in relation to anticipated benefits?
Nature medicine 2004;10(6):570-3.
-
2004: Fernandez Conrad V; Skedgel Chris; Weijer Charles
Considerations and costs of disclosing study findings to research participants.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2004;170(9):1417-9.
-
2004: Weijer Charles
The ethical analysis of risk in intensive care unit research.
Critical care (London, England) 2004;8(2):85-6.
-
2004: Weijer C; Miller P B
Protecting communities in pharmacogenetic and pharmacogenomic research.
The pharmacogenomics journal 2004;4(1):9-16.
-
2003: Miller Paul B; Weijer Charles
Will the real Charles Fried please stand up?
Kennedy Institute of Ethics journal 2003;13(4):353-7.
-
2003: Fernandez Conrad V; Kodish Eric; Weijer Charles
Importance of informed consent in offering to return research results to research participants.
Medical and pediatric oncology 2003;41(6):592-3.
-
2003: Fernandez Conrad V; Kodish Eric; Shurin Susan; Weijer Charles;
Offering to return results to research participants: attitudes and needs of principal investigators in the Children's Oncology Group.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2003;25(9):704-8.
-
2003: Miller Paul B; Weijer Charles
Rehabilitating equipoise.
Kennedy Institute of Ethics journal 2003;13(2):93-118.
-
2003: Weijer Charles
The ethics of placebo-controlled trials.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(6):1150-3.
-
2003: Fernandez Conrad V; Kodish Eric; Taweel Shaureen; Shurin Susan; Weijer Charles;
Disclosure of the right of research participants to receive research results: an analysis of consent forms in the Children's Oncology Group.
Cancer 2003;97(11):2904-9.
-
2003: Fernandez Conrad V; Kodish Eric; Weijer Charles
Informing study participants of research results: an ethical imperative.
IRB 2003;25(3):12-9.
-
2003: Weijer Charles; Miller Paul B
Therapeutic obligation in clinical research.
The Hastings Center report 2003;33(3):3.
-
2003: Weijer Charles; Akabayashi Akira
Unethical author attribution.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 2003;12(1):124-30.
-
2002: Weijer Charles
Continuing review of clinical research Canadian-style.
Clinical and investigative medicine. Médecine clinique et experimentale 2002;25(3):92-3.
-
2002: McRae Andrew D; Weijer Charles
Lessons from everyday lives: a moral justification for acute care research.
Critical care medicine 2002;30(5):1146-51.
-
2002: Weijer Charles
Placebo trials and tribulations.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;166(5):603-4.
-
2002: Weijer Charles; Glass Kathleen Cranley
The ethics of placebo-controlled trials.
The New England journal of medicine 2002;346(5):382-3.
-
2002: Weijer Charles; Anderson James A
A critical appraisal of protections for aboriginal communities in biomedical research.
Jurimetrics 2002;42(2):187-98.
-
2002: Anderson James A; Weijer Charles
The research subject as wage earner.
Theoretical medicine and bioethics 2002;23(4-5):359-76.
-
2002: Weijer Charles
I need a placebo like I need a hole in the head.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2002;30(1):69-72.
-
2001: Anderson J A; Weijer C
Minimal risk and its implications. Proceedings of the NCEHR National Workshop on Minimal Risk, March 31-April 1, 2000 held in Ottawa, Ontario, Canada.
NCEHR communiqué = Communiqué CNERH 2001;11(1):15-26.
-
2001: Weijer C
Continuing review of research approved by Canadian research ethics boards.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2001;164(9):1305-6.
-
2001: Singer P A; Barker G; Bowman K W; Harrison C; Kernerman P; Kopelow J; Lazar N; Weijer C; Workman S
Hospital policy on appropriate use of life-sustaining treatment. University of Toronto Joint Centre for Bioethics/Critical Care Medicine Program Task Force.
Critical care medicine 2001;29(1):187-91.
-
2000: Weijer C
Benefit-sharing and other protections for communities in genetic research.
Clinical genetics 2000;58(5):367-8.
-
2000: Miller P B; Weijer C
Moral solutions in assessing research risk.
IRB 2000;22(5):6-10.
-
2000: Weijer C; Shapiro S H; Cranley Glass K
For and against: clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial.
BMJ (Clinical research ed.) 2000;321(7263):756-8.
-
2000: Weijer C; Emanuel E J
Ethics. Protecting communities in biomedical research.
Science (New York, N.Y.) 2000;289(5482):1142-4.
-
2000: Weijer C
The ethical analysis of risk.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2000;28(4):344-61.
-
1999: Weijer C; Goldsand G; Emanuel E J
Protecting communities in research: current guidelines and limits of extrapolation.
Nature genetics 1999;23(3):275-80.
-
1999: Glass Kathleen C; Weijer Charles; Cournoyer Denis; Lemmens Trudo; Palmour Roberta M; Shapiro Stanley H; Freedman Benjamin
Structuring the review of human genetics protocols, part III: gene therapy studies.
IRB 1999;21(2):1-9.
-
1999: Weijer C
Placebo-controlled trials in schizophrenia: are they ethical? Are they necessary?
Schizophrenia research 1999;35(3):211-8; discussion 227-36.
-
1999: Weijer C
Selecting subjects for participation in clinical research: one sphere of justice.
Journal of medical ethics 1999;25(1):31-6.
-
1999: Weijer C
The analysis of risks and potential benefits in research.
NCEHR communiqué = Communiqué CNERH 1999;9(2):16-20.
-
1999: Weijer C; Crouch R A
Why should we include women and minorities in randomized controlled trials?
The Journal of clinical ethics 1999;10(2):100-6.
-
1999: Weijer C
Protecting communities in research: philosophical and pragmatic challenges.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 1999;8(4):501-13.
-
1998: Skrutkowski Myrian; Weijer Charles; Shapiro Stan; Fuks Abraham; Langleben Adrian; Freedman Benjamin
Monitoring informed consent in an oncology study posing serious risk to subjects.
IRB 1998;20(6):1-6.
-
1998: Weijer C; Freedman B; Shapiro S; Fuks A; Skrutkowska M; Sigurjonsdottir M
Assessing the interpretation of criteria for clinical trial eligibility: a survey of oncology investigators.
Clinical and investigative medicine. Médecine clinique et experimentale 1998;21(1):17-26.
-
1997: Glass Kathleen Cranley; Weijer Charles; Lemmens Trudo; Palmour Roberta M; Shapiro Stanley H
Structuring the review of human genetics protocols, Part II: diagnostic and screening studies.
IRB 1997;19(3-4):1-13.
-
1996: Glass Kathleen Cranley; Weijer Charles; Palmour Roberta M; Shapiro Stanley H; Lemmens Trudo M; Lebacqz Karen
Structuring the review of human genetics protocols: gene localization and identification studies.
IRB 1996;18(4):1-9.
-
1996: Weijer C; Freedman B; Fuks A; Robbins J; Shapiro S; Skrutkowska M
What difference does it make to be treated in a clinical trial? A pilot study.
Clinical and investigative medicine. Médecine clinique et experimentale 1996;19(3):179-83.
-
1996: Freedman B; Glass K C; Weijer C
Placebo orthodoxy in clinical research. II: Ethical, legal, and regulatory myths.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 1996;24(3):252-9.
-
1996: Freedman B; Weijer C; Glass K C
Placebo orthodoxy in clinical research. I: Empirical and methodological myths.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 1996;24(3):243-51.
-
1996: Weijer C
Evolving ethical issues in selection of subjects for clinical research.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 1996;5(3):334-45.
-
1995: Weijer C; Shapiro S; Fuks A; Glass K C; Skrutkowska M
Monitoring clinical research: an obligation unfulfilled.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1995;152(12):1973-80.
-
1995: Weijer C
Learning from the Dutch: physician-assisted death, slippery slopes and the Nazi analogy.
Health law review 1995;4(1):23-9.
-
1994: Weijer C; Fuks A
The duty to exclude: excluding people at undue risk from research.
Clinical and investigative medicine. Médecine clinique et experimentale 1994;17(2):115-22.
-
1992: Freedman B; Fuks A; Weijer C
Demarcating research and treatment: a systematic approach for the analysis of the ethics of clinical research.
Clinical research 1992;40(4):653-60.
Sign-in to see more
